Article
MAO-A and COMT genotypes as possible regulators of perinatal serotonergic symptoms after in utero exposure to SSRIs.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology - 1 May 2009
Hilli Johanna, Heikkinen Tuija, Rontu Riikka, Lehtimäki Terho, Kishida Ikuko, Aklillu Eleni, Bertilsson Leif, Vahlberg Tero, Laine Kari
Abstract excerpt
Intrauterine exposure to SSRIs in late pregnancy can cause various serotonergic symptoms in the newborns. We associated the severity of these symptoms to neurotransmitter concentrations and genetic polymorphisms in the cytochrome P450, MAO-A and COMT enzymes. Altogether 20 children with prenatal exposure to citalopram or fluoxetine were genotyped. Infants with two high-activity alleles of the MAO-A gene had...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
